APC News
Poll: Consumers like you, they really like you (well, those who know about you)
A new national poll gives some telling information about consumers’ views on compounding
February 28, 2025
Our tirzepatide memo to BoPs
We wrote a simple, 2-page memo for state boards explaining the current legal and regulatory situation around compounding tirzepatide.
February 28, 2025
About that Super Bowl ad…
The media has been turning to APC for perspective on the Hims & Hers Super Bowl ad … a lot.
February 21, 2025
Once more with monotone: FDA again clarifies discretion on tirzepatide copies
The FDA again clarified its enforcement discretion policy for compounded copies of tirzepatide injections.
February 21, 2025
Earlier news
February 14, 2025
Another loss for Novo
A federal judge has ruled against Novo Nordisk in a case the company made against a compounding pharmacy.
February 14, 2025
State advocacy updates: Feb. 14, 2025
Updates on Washington and Louisiana
February 7, 2025
Good news in the court
A federal court dismissed Novo Nordisk’s lawsuit against Live Well Drugstore — this is good news for a few reasons.
February 7, 2025
A(nother) California update
APC continues to press the California Board of Pharmacy on its (over-zealous) proposed rules on requirements for compounding Category 1 substances.
February 7, 2025
Meanwhile, in Mississippi…
The Mississippi Board of Nursing has issued a temporary rule regarding GLP-1 treatment that included a provision related to compounding.
February 7, 2025
Chasing shiny objects: Is there compounding after GLP1s?
Join us at the Owner Summit for a panel discussion and Q&A on the future beyond GLP-1 compounding.
February 7, 2025
CompPAC supports E&C chair (and he supports compounding)
Pharmacist Ross Jordan presented Congressman Brett Guthrie of Kentucky a check from CompPAC to show our support to a compounding supporter.
February 7, 2025
PFMs saving big on credit card fees
We said that at least half of our PFM members could save a lot, and we weren’t kidding.
January 24, 2025
FDA to continue enforcement discretion on compounded tirzepatide
Important answers to your questions about the current state of FDA’s enforcement when it comes to compounded tirzepatide injections.
January 24, 2025
Another reason to attend the Owner Summit
We’ve got another awesome keynote at the 2025 Owner Summit: “16 Ways to Improve Employee Engagement” with Allison Linney.
January 24, 2025
A different approach to regulation
The Texas State Board of Pharmacy is taking a different approach to USP chapter implementation.
January 17, 2025
OFA v. Califf: The latest
If you missed our email earlier this week, here’s an update for you on the Outsourcing Facilities Association/Farmakeio lawsuit against FDA.
